On demand

Cooley Rx series

Life Sciences Litigation: Biosimilars, 2023 Year in Review

December 11, 2023
Event details
December 11, 2023
12:00 – 1:00 pm Pacific Standard Time

Event summary

Cooley Rx is a virtual series focused on the life sciences and healthcare sectors. Join us as we discuss the top issues and trends in these industries – and provide decision-makers with information they can use to strengthen their organizations.

Life Sciences Litigation: Biosimilars, 2023 Year in Review

Over the past year, the landscape for biosimilars litigation has continued to evolve, as the field moves into a new wave of products and cases. Cooley lawyers Brianna PattersonGeoff Biegler and Michelle Rhyu recapped the most important cases, decisions and industry developments from the past year, as well as new strategy considerations gleaned from those developments – both from the reference product sponsor and biosimilar applicant perspectives. The discussion also included an overview of 2023’s biosimilar approvals, biosimilar-related post-grant proceedings and a discussion of what to watch for in 2024. 

View on demand

For more information, please email Megan Senerchia.

Cooley Rx programming

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.